Chilton Investment Co. LLC Buys 161 Shares of CVS Health Corporation (CVS)
Chilton Investment Co. LLC grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 4.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,552 shares of the pharmacy operator’s stock after buying an additional 161 shares during the period. Chilton Investment Co. LLC’s holdings in CVS Health Corporation were worth $286,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in CVS. Gemmer Asset Management LLC increased its position in CVS Health Corporation by 15.3% during the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after buying an additional 200 shares in the last quarter. TB Alternative Assets Ltd. purchased a new position in CVS Health Corporation during the second quarter worth $121,000. SRS Capital Advisors Inc. increased its position in CVS Health Corporation by 48.2% during the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after buying an additional 734 shares in the last quarter. Grace & White Inc. NY purchased a new position in CVS Health Corporation during the second quarter worth $199,000. Finally, Nadler Financial Group Inc. purchased a new position in CVS Health Corporation during the second quarter worth $202,000. 82.04% of the stock is owned by institutional investors.
Several equities research analysts have recently issued reports on CVS shares. Royal Bank Of Canada started coverage on CVS Health Corporation in a report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price objective on the stock. Robert W. Baird restated a “hold” rating and set a $77.00 price objective on shares of CVS Health Corporation in a report on Friday, October 27th. Loop Capital started coverage on CVS Health Corporation in a report on Thursday, August 24th. They set a “hold” rating and a $83.00 price objective on the stock. Jefferies Group LLC set a $86.00 price objective on CVS Health Corporation and gave the stock a “hold” rating in a report on Wednesday, October 18th. Finally, Wolfe Research cut CVS Health Corporation from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $89.00 to $82.00 in a report on Monday, August 14th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $85.82.
In other news, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health Corporation stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO David M. Denton sold 237,078 shares of CVS Health Corporation stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $79.65, for a total value of $18,883,262.70. Following the sale, the chief financial officer now directly owns 141,096 shares in the company, valued at $11,238,296.40. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 714,125 shares of company stock worth $58,119,381. 0.61% of the stock is currently owned by insiders.
CVS Health Corporation (CVS) opened at $70.26 on Friday. The company has a market capitalization of $70,706.84, a PE ratio of 12.22, a price-to-earnings-growth ratio of 1.20 and a beta of 0.86. CVS Health Corporation has a one year low of $66.45 and a one year high of $84.72. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05.
CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. The company had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The firm’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.64 earnings per share. sell-side analysts expect that CVS Health Corporation will post 5.9 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.85%. The ex-dividend date of this dividend was Monday, October 23rd. CVS Health Corporation’s dividend payout ratio is presently 41.32%.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.